Akebia Therapeutics, Inc. (AKBA)
1.365
-0.08
(-5.21%)
USD |
NASDAQ |
Jan 23, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Total Assets (Annual): 220.67M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Amgen, Inc. | 91.84B |
| Pfizer Inc. | 213.40B |
| Theravance Biopharma, Inc. | 354.16M |
| Zevra Therapeutics, Inc. | 178.13M |
| Organon & Co. | 13.10B |